Sharon McCarthy

1.8k total citations · 1 hit paper
28 papers, 1.1k citations indexed

About

Sharon McCarthy is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sharon McCarthy has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 17 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Sharon McCarthy's work include Prostate Cancer Treatment and Research (22 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Sharon McCarthy is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Sharon McCarthy collaborates with scholars based in United States, Germany and United Kingdom. Sharon McCarthy's co-authors include Simon Chowdhury, Neeraj Agarwal, Jinhui Li, Hirotsugu Uemura, Kim N., Byung Ha Chung, Margaret K. Yu, Anders Bjartell, Mustafa Özgüroğlu and Dingwei Ye and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Sharon McCarthy

24 papers receiving 1.1k citations

Hit Papers

Apalutamide for Metastatic, Castration-Sensitive Prostate... 2019 2026 2021 2023 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    2019 891 citations Kim N., Neeraj Agarwal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon McCarthy United States 8 962 341 326 217 175 28 1.1k
Álvaro Juárez Soto Spain 8 1.1k 1.1× 379 1.1× 345 1.1× 222 1.0× 201 1.1× 44 1.2k
Vahid Naini United States 8 1.1k 1.1× 417 1.2× 357 1.1× 244 1.1× 191 1.1× 21 1.2k
Per Rathenborg Denmark 11 923 1.0× 308 0.9× 325 1.0× 309 1.4× 182 1.0× 18 1.1k
Iris Kuss Germany 12 1.1k 1.2× 400 1.2× 400 1.2× 251 1.2× 224 1.3× 40 1.3k
Kris Deprince United States 7 948 1.0× 333 1.0× 312 1.0× 252 1.2× 167 1.0× 15 1.2k
Murilo Luz Brazil 7 952 1.0× 303 0.9× 324 1.0× 199 0.9× 175 1.0× 34 1.1k
Andrea Juliana Gomes United States 8 1.4k 1.4× 496 1.5× 450 1.4× 336 1.5× 245 1.4× 24 1.5k
Youyi Shu United States 9 827 0.9× 263 0.8× 290 0.9× 176 0.8× 146 0.8× 14 1.0k
S. Polyakov Belarus 8 811 0.8× 273 0.8× 281 0.9× 180 0.8× 153 0.9× 20 940
Eren Demirhan United States 8 678 0.7× 219 0.6× 231 0.7× 290 1.3× 126 0.7× 15 955

Countries citing papers authored by Sharon McCarthy

Since Specialization
Citations

This map shows the geographic impact of Sharon McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon McCarthy more than expected).

Fields of papers citing papers by Sharon McCarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon McCarthy. The network helps show where Sharon McCarthy may publish in the future.

Co-authorship network of co-authors of Sharon McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon McCarthy. A scholar is included among the top collaborators of Sharon McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon McCarthy. Sharon McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chaudhary, Ruchi, Amitabha Bhaumik, Angela Lopez‐Gitlitz, et al.. (2025). Radiographic progression without PSA progression in advanced prostate cancer patients.. Journal of Clinical Oncology. 43(5_suppl). 213–213.
3.
Gartrell, Benjamin A., Suneel Mundle, Sharon McCarthy, et al.. (2024). Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review. European Urology Oncology. 7(6). 1216–1227. 3 indexed citations
4.
Azad, Arun, Qiang Dong, Alicia K. Morgans, et al.. (2024). Apalutamide (APA) plus intermittent versus continuous androgen-deprivation therapy (ADT) in participants (pts) with metastatic castration-sensitive prostate cancer (mCSPC): LIBERTAS phase 3 study design.. Journal of Clinical Oncology. 42(4_suppl). TPS236–TPS236. 1 indexed citations
5.
Chung, Byung Ha, Jian Huang, Hiroji Uemura, et al.. (2023). Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial. Asian Journal of Andrology. 25(6). 653–661. 3 indexed citations
6.
Small, Eric J., Kim N., Simon Chowdhury, et al.. (2023). Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer. European Urology Oncology. 7(4). 844–852. 8 indexed citations
7.
Shen, John, Simon Chowdhury, Neeraj Agarwal, et al.. (2023). Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN. British Journal of Cancer. 130(1). 73–81. 8 indexed citations
8.
Feng, Felix Y., Matthew R. Smith, Fred Saad, et al.. (2023). Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 41(16_suppl). 5035–5035. 1 indexed citations
9.
McCarthy, Sharon, et al.. (2022). Breast cancer knowledge & information seeking among African American women below screening age. Patient Education and Counseling. 106. 194–200. 3 indexed citations
10.
11.
Feng, Felix Y., Shibu Thomas, Fred Saad, et al.. (2021). Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer. JAMA Oncology. 7(7). 1005–1005. 21 indexed citations
12.
13.
14.
Bjartell, Anders, Neeraj Agarwal, Lawrence I. Karsh, et al.. (2021). MP24-08 RELATIONSHIPS OF SITES AND BURDEN OF METASTASES WITH LONG-TERM OUTCOMES AND MOLECULAR SUBTYPES IN TITAN. The Journal of Urology. 206(Supplement 3).
15.
Feng, Felix Y., Clemente Aguilar-Bonavides, Justin Lucas, et al.. (2021). Molecular determinants associated with long-term response to apalutamide (APA) in nonmetastatic castration-resistant prostate cancer (nmCRPC).. Journal of Clinical Oncology. 39(6_suppl). 8–8. 4 indexed citations
16.
17.
McCarthy, Sharon, et al.. (2021). Opportunities for Cancer Health Care Disparities and Care Delivery Research: An Analysis of the NCI Health Care Delivery Research Program Portfolio. Journal of Health Care for the Poor and Underserved. 32(3). 1475–1492. 8 indexed citations
18.
Bjartell, Anders, Neeraj Agarwal, Byung Ha Chung, et al.. (2020). PD10-11 APALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN TITAN: PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN RESPONSES. The Journal of Urology. 203(Supplement 4). 4 indexed citations
19.
N., Kim, Fred Saad, Simon Chowdhury, et al.. (2020). Prostate-specific antigen (PSA) kinetics in patients (pts) with advanced prostate cancer treated with apalutamide: Results from the TITAN and SPARTAN studies.. Journal of Clinical Oncology. 38(15_suppl). 5541–5541. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Álvaro Juárez Soto Breakdown of academic impact, for papers by Vahid Naini Breakdown of academic impact, for papers by Per Rathenborg Breakdown of academic impact, for papers by Iris Kuss Breakdown of academic impact, for papers by Kris Deprince Breakdown of academic impact, for papers by Murilo Luz Breakdown of academic impact, for papers by Andrea Juliana Gomes Breakdown of academic impact, for papers by Youyi Shu Breakdown of academic impact, for papers by S. Polyakov Breakdown of academic impact, for papers by Eren Demirhan
Rankless by CCL
2026